Antifungal resistance is growing – will new treatments turn the tables. Very happy to be featured in this important Nature outlook alongside many icons of the Mycology field. www.nature.com/articles/d41...

Excited to share our new publication: Clinical Characteristics, Management and Outcomes of Non-ICU Candidemia – a subanalysis of the ECMM Candida III multinational European cohort study. 😊 academic.oup.com/ofid/article... @martinhoenigl.bsky.social @olivercornely.bsky.social

Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review link.springer.com/article/10.1... @martinhoenigl.bsky.social @agocarvalho.bsky.social @simonfeys.bsky.social

Incidence and outcomes of influenza-associated pulmonary aspergillosis and the role of antifungal prophylaxis: a structured literature review Work informing aims of @galactic-europe.bsky.social Comgrats to all involved. rdcu.be/fazXN

Clinical characteristics, management and outcomes of non-ICU candidemia: Sub-analysis of the ECMM Candida III multinational European observational cohort study url: academic.oup.com/ofid/article...

Mapping the landscape of endemic mycoses in India: Insights from a systematic review of reported cases spanning six decades (1960-2025) @ofidjournal.bsky.social @drarghadip.bsky.social @grthompsonmd.bsky.social url: academic.oup.com/ofid/article...

Mucorales PCR testing in Respiratory and Biopsy Samples from Immunocompromised Patients with Invasive Pulmonary Aspergillosis and other Mold Infections: Results from a Multicenter ECMM Study ✅ Just Accepted https://bit.ly/3NxZoD2

Evidence that increased azole persistence and stress resistance precede the in vivo evolution of azole resistance in Aspergillus fumigatus | Microbiology Spectrum journals.asm.org/doi/10.1128/...

Treatment Monitoring and Outcome Prediction in Invasive Aspergillosis using Immunologic. Results of an ECMM multicenter study. Big 🙏 to all involved and driving this project @agocarvalho.bsky.social and many more Markers url: academic.oup.com/jid/article/...

Diagnostic accuracy of Mucorales PCR testing in bronchoalveolar lavage fluid samples: a retrospective analysis of a prospectively collected cohort - Clinical Microbiology and Infection www.clinicalmicrobiologyandinfection.org/article/S119...

Rapid and reliable diagnosis of mucormycosis using colorimetric loop-mediated isothermal amplification | Journal of Clinical Microbiology @ecmmcandidaiv.bsky.social @galactic-europe.bsky.social journals.asm.org/doi/10.1128/...

Upcoming @idsainfo.bsky.social Immunocompromised Host COP and @msgerc.bsky.social webinar: Feb 10, 2026 10:00 AM Central "Testing Rationally in Mycology: Using Fungal Diagnostics to Drive Better Antifungal Decisions" Sign up here: societycentral.zoom.us/webinar/regi...

New webinar on fungal diagnostics! Link in next post

Update on Candida IV study at #TIMM2025 Still open for registration 🔬🧫🧪 Join now!

Early mycological clearance in uncomplicated candidaemia can improve outcomes, reduce ICU stay, and lower healthcare costs. Timely antifungal therapy is key. Read more: doi.org/10.1111/myc.... @martinhoenigl.bsky.social #Candidaemia #AntifungalTherapy #InfectiousDiseases #ICU #Healthcare

link.springer.com/article/10.1... rdcu.be/eL6ug

2025 #Candida #Guidelines by ECMM, ISHAM, ASM + Summary recs here; full evidence, methods + pediatric guidance in appendix. www.thelancet.com/journals/lan... @olivercornely.bsky.social @martinhoenigl.bsky.social @anaalastruey.bsky.social @germhuntermd.bsky.social @fhagen.bsky.social

GALActIC Project – EU Collaboration Against IAPA | Consortium Meeting on Future Planning in Bilbao 🇪🇸 Galactic Europe: lnkd.in/d77xessA @martinhoenigl.bsky.social @simonfeys.bsky.social @agocarvalho.bsky.social

✨📄 What about the untapped therapeutic potential of the immune response in invasive aspergillosis ? Here’s some rational, pre-clinical and clinical evidence. Huge thanks to our amazing 🌍 team! 🔗 bit.ly/46kajHr @simonfeys.bsky.social @agocarvalho.bsky.social @martinhoenigl.bsky.social

🔥🗞️Olorofim for the treatment of invasive fungal diseases in patients with few or no therapeutic options: a single-arm, open-label, phase 2b study. Groundbreaking work on a very promising new antifungal. Free access here: authors.elsevier.com/c/1lHca5E-Uo...

🚨Our latest review in Thorax about the impact of climate change focusing on fungal pathogens in Europe 🌍 A truly enjoyable collaboration with Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social and @mbottery.bsky.social thorax.bmj.com/content/earl...

Addressing Antifungal Drug Resistance — A “One Health–One World” Challenge @grthompsonmd.bsky.social and Angel Desai www.nejm.org/doi/full/10....

Climate change: shifting boundaries of fungal disease in Europe and beyond New review in Thorax by @mbottery.bsky.social Sarah Sedik @germhuntermd.bsky.social @martinhoenigl.bsky.social @normanvanrhijn.bsky.social thorax.bmj.com/content/thor... #MedSky #IDSky #PulmSky #ClimateSky #MedMycoSky

Diagnosis and Management of Candida Endophthalmitis and Chorioretinitis Nate Permpalung, Sarah Sedik, Pete Pappas, @martinhoenigl.bsky.social, @drluiso.bsky.social in @cmijournal.bsky.social www.clinicalmicrobiologyandinfection.com/article/S119...

Proud to present the progress of ECMM Candida IV study at #ISHAM2025 Still open for participation! @martinhoenigl.bsky.social

Yesterday at ISHAM 2025, Danila Seidel explored how environmental extremes can spark fungal outbreaks 🌪️🌱 A powerful reminder of climate’s role in emerging mycoses. #ISHAM2025 #FungalOutbreaks #ClimateAndHealth #MedicalMycology

Did you know..75% of wine has significant levels of azole antifungals in it? (German wine anyway) Potential consequences for driving resistance... #IDSky #ISHAM

Happy to meet some wonderful colleagues & brilliant minds in Medical Mycology. @martinhoenigl.bsky.social @germhuntermd.bsky.social at #ISHAM2025 It has been an amazing congress with enriching academic sessions, lovely food & great hospitality at such a captivating location @fozdoiguacu.bsky.social

Thrilled to see Dr. Jon Salmanton-García receive the GEMICOMED Young Researcher Award 2025! His impactful research on invasive fungal & viral infections in hematologic malignancies is shaping the future of mycology: www.journalofinfection.com/article/S016... #FungalResearch #Mycology

Exciting news! The ECMM Candida IV study is now featured on the ECMM website! Find all the details here: www.ecmm.info/working-grou... @martinhoenigl.bsky.social

Sampling different types of grains at local markets in Namibia starting our project Fungal diversity of processed staple cereals from rural subsistence farming communities in Namibia 🙏🏻🙏🏻to colleagues from University of Namibia for hosting me

Honored to present today at ESCMID Global in Vienna: Ibrexafungerp salvage results from 233 patients in the FURI study — showing high success rates! 🔬💪 A promising new tool in the antifungal pipeline. #ESCMID2025 #FURIstudy #Ibrexafungerp #Antifungals #InfectiousDiseases

ECMM Candida IV Study is still open for participation Global study on non-albicans candidemia Requirements: 🔬Clinical data + isolates (no limit per site) 📅Apr 2024-Sep 2025 📦Ship isolates in one batch at study end 💰Case-based reimbursement available @martinhoenigl.bsky.social

👉Participate in the ECMM Candida IV Study 🌍wide study on candidemia caused by non-albicans Candida Requirement: clinical data & isolate (not req for C.auris) Observation period: 04/2024 - 09/2025 Interested? Email [email protected]

On April 1, 2025, our project officially started. A significant milestone that we have worked towards for a long time. Now, we look forward to taking the next steps together. @martinhoenigl.bsky.social @simonfeys.bsky.social @agocarvalho.bsky.social

Projekt „GALActIC“ startet: Biomarker für Pilzinfektionen erforscht www.medunigraz.at/news/detail/...

🔬💡 ICVS Researchers Join Innovative GALActIC Study to Combat IAPA! Researchers of the I3D team are part of this European project, aiming to improve the identification and treatment of Influenza-associated Pulmonary Aspergillosis and enhance patient care! 🙌 More at: icvs.uminho.pt/icvs-researc...

A potentially new antifungal class: Mandimycin, polyene-like but targeting phospholipids, rather than ergosterol. ✅activity against yeasts in vivo 🐁 With insights from @olivercornely.bsky.social @martinhoenigl.bsky.social & David Denning www.science.org/content/arti...

Deadly fungi are becoming drug-resistant. A new compound could beat them | Science | AAAS @kakape.bsky.social www.science.org/content/arti...

🔬 New research highlights a potential game-changer in treating invasive mould infections! 🦠 Patients show increased PD-1 expression, suggesting immune checkpoint inhibitors could help fight these deadly infections. More studies needed! 💡 onlinelibrary.wiley.com/doi/10.1111/... #Immunotherapy

New Medical Study Starting Soon 🔬 The logo was designed in collaboration with Galactic Partners, with professional support from Esra Sedik. Follow us for more! @martinhoenigl.bsky.social @agocarvalho.bsky.social @simonfeys.bsky.social

Are contemporary antifungal doses sufficient for critically ill patients? Outcomes from an international, multicenter PK study for Screening Antifungal Exposure in Intensive Care Units (SAFE-ICU) J Roberts etc TLDR: ++variable, need tailored approach w TDM link.springer.com/article/10.1...

🌍 Fungal Care Gaps: Brazil vs. Europe 🇧🇷➡️🇪🇺 Fungal infections are a global challenge with uneven access to diagnostic and treatment. Europe has more labs, better tests, and antifungal access, while Brazil faces greater threats from Cryptococcus and Histoplasma. journals.asm.org/doi/epub/10....

It’s out! A pleasure to work with @alukmd.bsky.social on the latest #fungal update of the ID Clinics of North America. I rembember saving money as a med student to buy them… #FullCircle #IDSky #MedSky

Prevalence of injecting-related bacterial and fungal infection among people who inject drugs: a systematic review and meta-analysis ✅ Just Accepted #IDSky

Despite being vastly outnumbered by bacteria, fungi in our microbiome still play a significant role in our health. In today’s episode, we learn about the “mycobiome.” Plus, turmoil at the NIH. Listen here 🎧: buff.ly/4ii9d2g

Antifungal pipeline: New tools for the treatment of mycoses. Focus on LMICs where many dont have access to current antifungals. Updated maps on fungal availability in LMICS. Thanks to a fantastic group of authors www.sciencedirect.com/science/arti...

Fungal Infections in People Who Use Drugs Jose Portugal Gonzales & @drluiso.bsky.social academic.oup.com/ofid/advance...